Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization

BACKGROUND: Transarterial chemoembolization (TACE) stands for the most commonly utilized therapy for hepatocellular carcinoma (HCC) worldwide. This study was to explore the potential predictive and prognostic roles of LAG-3 and PD-L1 as serum biomarkers in HCC patients underwent TACE treatment. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Mengzhou, Qi, Feng, Rao, Qianwen, Sun, Jialei, Du, Xiaojing, Qi, Zhuoran, Yang, Biwei, Xia, Jinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530014/
https://www.ncbi.nlm.nih.gov/pubmed/34691076
http://dx.doi.org/10.3389/fimmu.2021.754961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530014/
https://www.ncbi.nlm.nih.gov/pubmed/34691076
http://dx.doi.org/10.3389/fimmu.2021.754961

Ejemplares similares